Gastro Medical News about stent

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Drug-eluting stent in malignant biliary obstruction
Journal of Hepato-Biliary-Pancreatic Surgery, 07/01/09

Lee DK - The authors expect and hope DES will work effectively for tumor cells in diverse ways and, more importantly, will prolong stent patency and the patients’ survival periods. But considerable investigation and a clinical study of DES will be required to achieve these goals.

Exclusive Author Commentary
Dong Ki Lee, 07/01/09

I will continue to develope the DES effectivity by prolonging the drug release. And examine the various chemotherapeutic agent to achieve the ideal DES for the patients with malignat bile duct obstruction. I shall expedite the availability of the DES to the market.

<< Previous
Meta-analysis: longitudinal studies of serum vitamin D and...

Next >>
Uncoupling Protein-1 and related mRNAs in Human Epicardial and...